Simon Raffel

3.7k total citations · 1 hit paper
27 papers, 920 citations indexed

About

Simon Raffel is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Simon Raffel has authored 27 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Molecular Biology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Simon Raffel's work include Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Simon Raffel is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Simon Raffel collaborates with scholars based in Germany, Switzerland and United States. Simon Raffel's co-authors include Andreas Trumpp, Christoph Lutz, Anthony D. Ho, Daniel Nowak, Simon Haas, Tobias Boch, Lars M. Steinmetz, Lars Velten, Eike C. Buss and Marieke Essers and has published in prestigious journals such as Nature Communications, Blood and Nature Cell Biology.

In The Last Decade

Simon Raffel

26 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human haematopoietic stem cell lineage commitment is a continuous process

2017 539 citations Lars Velten, Simon Haas et al. Nature Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Raffel Germany	12	510	414	310	147	145	27	920
Sonja Babovic Canada	9	415 0.8×	308 0.7×	296 1.0×	134 0.9×	101 0.7×	11	813
Mathilde Broekhuis Netherlands	13	833 1.6×	311 0.8×	207 0.7×	371 2.5×	135 0.9×	19	1.1k
Ryu Nakamura Japan	8	510 1.0×	437 1.1×	228 0.7×	105 0.7×	250 1.7×	22	984
Judith Schütte United Kingdom	14	1.0k 2.0×	519 1.3×	358 1.2×	131 0.9×	168 1.2×	24	1.5k
Eike C. Buss Germany	13	494 1.0×	537 1.3×	438 1.4×	107 0.7×	397 2.7×	31	1.2k
Florian Grünschläger Germany	4	295 0.6×	184 0.4×	200 0.6×	76 0.5×	111 0.8×	5	605
Ruggiero Norfo Italy	11	485 1.0×	449 1.1×	199 0.6×	208 1.4×	86 0.6×	19	845
Timothy M. Chlon United States	17	532 1.0×	403 1.0×	202 0.7×	109 0.7×	79 0.5×	32	936
Jianlong Sun United States	12	930 1.8×	545 1.3×	423 1.4×	183 1.2×	168 1.2×	24	1.5k
Pablo Hernández-Malmierca Germany	3	350 0.7×	221 0.5×	188 0.6×	107 0.7×	126 0.9×	3	628

Countries citing papers authored by Simon Raffel

Since Specialization

Citations

This map shows the geographic impact of Simon Raffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Raffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Raffel more than expected).

Fields of papers citing papers by Simon Raffel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Raffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Raffel. The network helps show where Simon Raffel may publish in the future.

Co-authorship network of co-authors of Simon Raffel

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Raffel. A scholar is included among the top collaborators of Simon Raffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Raffel. Simon Raffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poisa-Beiro, Laura, Jonathan J. M. Landry, Bowen Yan, et al.. (2025). A Senescent Cluster in Aged Human Hematopoietic Stem Cell Compartment as Target for Senotherapy. International Journal of Molecular Sciences. 26(2). 787–787. 1 indexed citations

Chen, Qian, Yao Hao, Brigitte Neuber, et al.. (2024). Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. Journal of Hematology & Oncology. 17(1). 85–85. 9 indexed citations

Schmidt, Christina, Christian Rohde, Cornelius Pauli, et al.. (2023). The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. Leukemia. 37(8). 1611–1625. 14 indexed citations

Baccelli, Irène, Lennart Lenk, Beat Bornhäuser, et al.. (2023). Abstract 2957: CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis. Cancer Research. 83(7_Supplement). 2957–2957. 1 indexed citations

Chen, Qian, Peter‐Martin Bruch, Carolin Kolb, et al.. (2023). Improving Anti-Tumor Efficacy of CAR T-Cell Therapy for Acute Myeloid Leukemia (AML): Results from a Multi-Drug Interaction Screening Approach. Blood. 142(Supplement 1). 5969–5969. 1 indexed citations

Goekbuget, Nicola, Stefan Schwartz, Christoph Faul, et al.. (2023). Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with Ph/BCR::ABL Negative B-Precursor Adult Lymphoblastic Leukemia (ALL): Preliminary Results of the GMALL Bold Trial. Blood. 142(Supplement 1). 964–964. 20 indexed citations

Fransecky, Lars, Walter Fiedler, Christoph Röllig, et al.. (2023). Venetoclax and Blinatumomab for Adult Patients with Relapsed/Refractory or MRD Positive Ph-Negative B-Precursor ALL: First Results of the GMALL-Bliven Trial. Blood. 142(Supplement 1). 1502–1502. 2 indexed citations

Poisa-Beiro, Laura, Jonathan J. M. Landry, Simon Raffel, et al.. (2022). Glucose Metabolism and Aging of Hematopoietic Stem and Progenitor Cells. International Journal of Molecular Sciences. 23(6). 3028–3028. 9 indexed citations

Kotrová, Michaela, Heiko Trautmann, Nael Alakel, et al.. (2022). Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods. Blood Advances. 6(10). 3006–3010. 22 indexed citations

10.

Goekbuget, Nicola, Andreas Viardot, Björn Steffen, et al.. (2022). Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols. Blood. 140(Supplement 1). 121–123. 8 indexed citations

11.

Velten, Lars, Pablo Hernández-Malmierca, Simon Raffel, et al.. (2021). Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics. Nature Communications. 12(1). 1366–1366. 89 indexed citations

12.

Raffel, Simon, Paul Theodor Pyl, Eike C. Buss, et al.. (2021). Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy‐resistant preleukemic clones. International Journal of Cancer. 148(11). 2825–2838. 6 indexed citations

13.

Renders, Simon, Aino‐Maija Leppä, Alexander Waclawiczek, et al.. (2021). Leukemic Stem Cells of Monocytic AMLs Are Not-Resistant to BCL-2 Inhibition. Blood. 138(Supplement 1). 3469–3469. 1 indexed citations

14.

Poisa-Beiro, Laura, Jonathan J. M. Landry, Sven W. Sauer, et al.. (2020). Glycogen accumulation, central carbon metabolism, and aging of hematopoietic stem and progenitor cells. Scientific Reports. 10(1). 11597–11597. 14 indexed citations

15.

Raffel, Simon, Jenny Hansson, Mattia Falcone, et al.. (2018). Characteristic Amino Acid and Energy Metabolism in AML Stem Cells As Revealed By Quantitative Multiplex Proteomics. Blood. 132(Supplement 1). 2780–2780. 1 indexed citations

16.

Wang, Wenwen, Thomas Stiehl, Simon Raffel, et al.. (2017). Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia. Haematologica. 102(9). 1567–1577. 30 indexed citations

17.

Velten, Lars, Simon Haas, Simon Raffel, et al.. (2017). Human haematopoietic stem cell lineage commitment is a continuous process. Nature Cell Biology. 19(4). 271–281. 539 indexed citations breakdown →

18.

Stockklausner, Clemens, Simon Raffel, Julia Klermund, et al.. (2015). A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition. Aging. 7(11). 911–927. 12 indexed citations

19.

Krestel, Heinz, Simon Raffel, Marec von Lehe, et al.. (2013). Differences between RNA and DNA due to RNA editing in temporal lobe epilepsy. Neurobiology of Disease. 56. 66–73. 20 indexed citations

20.

Klimmeck, Daniel, Jenny Hansson, Simon Raffel, et al.. (2012). Proteomic Cornerstones of Hematopoietic Stem Cell Differentiation: Distinct Signatures of Multipotent Progenitors and Myeloid Committed Cells. Molecular & Cellular Proteomics. 11(8). 286–302. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact